richard kim, md, considers the effectiveness of combination sorafenib and tace in hcc patients
Published 6 years ago • 60 plays • Length 0:49
Download video MP4
Download video MP3
Similar videos
-
1:00
richard finn, md, considers the effectiveness of sorafenib in newly diagnosed hcc
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
0:43
richard kim, md, on the role of braf mutations in treatment of cholangiocarcinoma
-
1:47
richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
-
1:16
richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
1:33
richard kim, md, offers analysis of the rainfall study in metastatic gastric & ge junction cancer
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
0:38
comparison of sorafenib versus hepatic arterial infusion chemotherapy-based treatment... | rtcl.tv
-
4:33
results from a phase iii study of sorafenib and sbrt for hepatocellular carcinoma
-
0:49
nevena damjanov, md, considers the shortcomings of recist in measuring efficacy in hcc patients
-
55:56
“update on the treatment of hepatocellular carcinoma and current research” by richard lee, md
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
2:13
progress against pancreatic cancer: clifford cho, m.d.
-
20:15
ablation, chemoembolization and radioembolization in primary liver cancer / hepatocellular carcinoma
-
0:57
dr. richards on using parp inhibitors in mutated metastatic pancreatic cancer
Clip.africa.com - Privacy-policy